Why is Agenus, Inc. ?
- Poor long term growth as Operating profit has grown by an annual rate 12.76% of over the last 5 years
- The company has a negative book value of Rs 271.11 crore
- The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward
- The company has declared positive results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD -87.53 MM
- RAW MATERIAL COST(Y) Fallen by -14.27% (YoY)
- NET SALES(Q) At USD 33.74 MM has Grown at 18.17%
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -36.40%, its profits have risen by 66.8%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 2.79% over the previous quarter.
How much should you hold?
- Overall Portfolio exposure to Agenus, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Agenus, Inc. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD -87.53 MM
Fallen by -14.27% (YoY
At USD 33.74 MM has Grown at 18.17%
Highest at USD 15.64 MM
Highest at 46.35 %
Highest at USD 40.56 MM
Highest at USD 40.58 MM
Lowest at USD 37.99 MM
Lowest at 4.55 times
Here's what is working for Agenus, Inc.
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Operating Cash Flows (USD MM)
Net Sales (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Raw Material Cost as a percentage of Sales
Here's what is not working for Agenus, Inc.
Cash and Cash Equivalents
Debtors Turnover Ratio






